Episode # 50 • 10 Mar 2026
Beyond the Beam: Integrating Radiopharmaceuticals into Modern Oncology Practice
Though relatively new, there is a rapidly growing interest in the field of therapeutic radiopharmaceuticals and their potential to play a significant role in cancer treatment. This episode of BackTable Tumor Board covers recent developments in radiopharmaceutical therapies with radiation oncologists Dr. Dustin Boothe and Dr. Ryan Funk, where they discuss efficacy, side effects, and better tolerability of modern radiopharmaceuticals compared to older ones.
Funding Label Rich Text
Timestamps
00:00 - Introduction
02:54 - Understanding Radiopharmaceutical Terminology
04:40 - The Evolution of Radiopharmaceuticals
07:07 - The Rise of Targeted Radiopharmaceutical Therapies
12:35 - Radiation Oncologists’ Role in Systemic Therapy
23:55 - Challenges and Strategies in Practice Development
30:33 - Starting Up a Radiopharmaceutical Practice: Challenges, Authorized Users & RAM Licensing
37:47 - Advancing Practices with Clinical Trials and Dosimetry
44:48 - Future of Radiopharmaceutical Therapy
52:39 - Final Thoughts
Resources
You may also like
More about this episode
Dr. Boothe and Dr. Funk cover the roles of radiation oncologists in treating patients and collaborating with different specialists, the challenges in starting a radiopharmaceutical program, and the importance of having an authorized user and radioactive materials license. They also delve into the promising future of radiopharmaceuticals, emphasizing potential advancements such as personalized dosimetry, new indications, and combination therapies.
https://cancercare.siemens-healthineers.com/products/software/digital-oncology/aria-core-for-theranostics
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.